Ideaya Biosciences Stock Options
| IDYA Stock | USD 26.00 0.84 3.34% |
Ideaya Biosciences' latest option contracts expiring on January 17th 2025 are carrying combined implied volatility of 0.56. The Ideaya Biosciences option chain provides detailed quote and price information for the current Ideaya Biosciences option contracts. It shows all of Ideaya Biosciences' listed puts, calls, expiration dates, strike prices, and other pricing information.
Ideaya Biosciences Maximum Pain Price Across 2025-01-17 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Ideaya Biosciences close to expiration to expire worthless. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, Ideaya Biosciences' option sellers may reap the most after selling more options than buying, causing them to expire worthless.
In The Money vs. Out of Money Option Contracts on Ideaya Biosciences
Analyzing Ideaya Biosciences' in-the-money options over time can help investors to take a profitable long position in Ideaya Biosciences regardless of its overall volatility. This is especially true when Ideaya Biosciences' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Ideaya Biosciences' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Ideaya Biosciences' stock while costing only a fraction of its price.
Ideaya Biosciences' stock options are financial instruments that give investors the right to buy or sell shares of Ideaya Biosciences common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Ideaya stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Ideaya Biosciences' stock price goes up or down, the stock options follow.
At present, Ideaya Biosciences' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Total Equity is expected to grow to 6,038, whereas Sale Purchase Of Stock is forecasted to decline to about 64.4 M. Ideaya Current Options Market Mood
Ideaya Biosciences' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Ideaya Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Unfortunately, most Ideaya Biosciences' options investors are not very successful. Ideaya Biosciences' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Ideaya contract
Base on the Rule 16, the options market is currently suggesting that Ideaya Biosciences will have an average daily up or down price movement of about 0.035% per day over the life of the 2025-01-17 option contract. With Ideaya Biosciences trading at USD 26.0, that is roughly USD 0.0091. If you think that the market is fully incorporating Ideaya Biosciences' daily price movement you should consider buying Ideaya Biosciences options at the current volatility level of 0.56%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Ideaya |
Purchasing Ideaya Biosciences options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Ideaya calls. Remember, the seller must deliver Ideaya Biosciences stock to the call owner when a call is exercised.
Ideaya Biosciences Option Chain
When Ideaya Biosciences' strike price is surpassing the current stock price, the option contract against Ideaya Biosciences stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Ideaya Biosciences' option chain is a display of a range of information that helps investors for ways to trade options on Ideaya. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Ideaya. It also shows strike prices and maturity days for a Ideaya Biosciences against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | IDYA250117C00020000 | 0 | 20.0 | 15.2 - 19.5 | 15.2 | |
Call | IDYA250117C00022500 | 0 | 22.5 | 18.4 - 23.0 | 18.4 | |
Call | IDYA250117C00025000 | 0 | 25.0 | 16.4 - 21.0 | 16.4 | |
Call | IDYA250117C00030000 | 0 | 30.0 | 12.8 - 17.5 | 12.8 | |
Call | IDYA250117C00035000 | 0 | 35.0 | 9.5 - 14.0 | 9.5 | |
Call | IDYA250117C00040000 | 0 | 40.0 | 7.0 - 11.5 | 7.0 | |
Call | IDYA250117C00045000 | 0 | 45.0 | 4.9 - 9.5 | 4.9 | |
Call | IDYA250117C00050000 | 0 | 50.0 | 3.6 - 8.0 | 3.6 | |
Call | IDYA250117C00055000 | 0 | 55.0 | 2.2 - 6.5 | 2.2 | |
Call | IDYA250117C00060000 | 0 | 60.0 | 1.6 - 6.0 | 1.6 | |
Put | IDYA250117P00020000 | 0 | 20.0 | 0.0 - 2.85 | 2.85 | |
Put | IDYA250117P00022500 | 0 | 22.5 | 0.0 - 5.0 | 5.0 | |
Put | IDYA250117P00025000 | 0 | 25.0 | 0.1 - 4.9 | 0.1 | |
Put | IDYA250117P00030000 | 0 | 30.0 | 0.2 - 5.0 | 0.2 | |
Put | IDYA250117P00035000 | 0 | 35.0 | 1.9 - 6.5 | 1.9 | |
Put | IDYA250117P00040000 | 0 | 40.0 | 4.0 - 8.6 | 4.0 | |
Put | IDYA250117P00045000 | 0 | 45.0 | 6.6 - 11.2 | 6.6 | |
Put | IDYA250117P00050000 | 0 | 50.0 | 10.1 - 14.8 | 10.1 | |
Put | IDYA250117P00055000 | 0 | 55.0 | 13.7 - 18.5 | 13.7 | |
Put | IDYA250117P00060000 | 0 | 60.0 | 18.0 - 22.4 | 18.0 |
Ideaya Total Stockholder Equity
Total Stockholder Equity |
|
Ideaya Biosciences Corporate Management
| Mick OQuigley | Chief Development | Profile | |
| Stu Dorman | Chief Officer | Profile | |
| Paul Stone | CFO VP | Profile | |
| JD Esq | Chief Secretary | Profile | |
| Matthew MD | VP Oncology | Profile | |
| Esq JD | Gen VP | Profile | |
| Stuart Dorman | Chief Officer | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ideaya Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For information on how to trade Ideaya Stock refer to our How to Trade Ideaya Stock guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ideaya Biosciences. If investors know Ideaya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ideaya Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.33) | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets | Return On Equity |
The market value of Ideaya Biosciences is measured differently than its book value, which is the value of Ideaya that is recorded on the company's balance sheet. Investors also form their own opinion of Ideaya Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Ideaya Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ideaya Biosciences' market value can be influenced by many factors that don't directly affect Ideaya Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ideaya Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ideaya Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ideaya Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.